Cargando…

Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome

Hepatic sinusoidal obstruction syndrome (HSOS) is a serious side effect of oxaliplatin (OXA) treatment. The present study aimed to establish a reproducible mouse model of OXA-induced HSOS and to preliminarily explore the underlying molecular mechanisms using mRNA microarray analysis. A total of 45 C...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Chen, Cheng, Xinwei, Gao, Ping, Gao, Qianyan, Wang, Ximin, Liu, Dong, Ren, Xiuhua, Zhang, Chengliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551404/
https://www.ncbi.nlm.nih.gov/pubmed/36177905
http://dx.doi.org/10.3892/mmr.2022.12862
_version_ 1784806091274584064
author Zhu, Chen
Cheng, Xinwei
Gao, Ping
Gao, Qianyan
Wang, Ximin
Liu, Dong
Ren, Xiuhua
Zhang, Chengliang
author_facet Zhu, Chen
Cheng, Xinwei
Gao, Ping
Gao, Qianyan
Wang, Ximin
Liu, Dong
Ren, Xiuhua
Zhang, Chengliang
author_sort Zhu, Chen
collection PubMed
description Hepatic sinusoidal obstruction syndrome (HSOS) is a serious side effect of oxaliplatin (OXA) treatment. The present study aimed to establish a reproducible mouse model of OXA-induced HSOS and to preliminarily explore the underlying molecular mechanisms using mRNA microarray analysis. A total of 45 C57BL/6 male mice were randomly divided into five groups: Control, 5 mg/kg OXA, 10 mg/kg OXA, 15 mg/kg OXA and 20 mg/kg OXA. The mice were respectively injected intraperitoneally with 5% glucose solution, or 5, 10, 15 or 20 mg/kg OXA solution once a week for 6 consecutive weeks. The body weight of the mice was recorded every day. The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined. Hematoxylin and eosin staining, Sirius red staining and scanning electron microscopy were used to identify pathological changes. mRNA microarray was used to analyze changes in the gene expression profiles mainly from the functional aspects of Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes. The oxidation mechanism was verified by measuring oxidative stress-related markers and reactive oxygen species with dihydroethidium probe technology, according to the microarray results. Among all of the OXA groups, 10 mg/kg OXA resulted in an acceptable survival rate of 78%. The mice showed obvious splenomegaly, increases in serum levels of ALT and AST, aggravation of liver pathological injuries and hepatic sinusoidal injuries. The microarray results suggested that mRNA expression changes after OXA treatment were associated with ‘oxidative stress’, ‘coagulation function’, ‘steroid anabolism’ and ‘pro-inflammatory responses’. The results confirmed that OXA aggravated oxidative damage in the livers of the mice. The present study successfully established a mouse model of OXA-induced HSOS and preliminarily analyzed the underlying molecular mechanisms involved, thus laying a foundation for a subsequent in-depth study.
format Online
Article
Text
id pubmed-9551404
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-95514042022-10-15 Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome Zhu, Chen Cheng, Xinwei Gao, Ping Gao, Qianyan Wang, Ximin Liu, Dong Ren, Xiuhua Zhang, Chengliang Mol Med Rep Articles Hepatic sinusoidal obstruction syndrome (HSOS) is a serious side effect of oxaliplatin (OXA) treatment. The present study aimed to establish a reproducible mouse model of OXA-induced HSOS and to preliminarily explore the underlying molecular mechanisms using mRNA microarray analysis. A total of 45 C57BL/6 male mice were randomly divided into five groups: Control, 5 mg/kg OXA, 10 mg/kg OXA, 15 mg/kg OXA and 20 mg/kg OXA. The mice were respectively injected intraperitoneally with 5% glucose solution, or 5, 10, 15 or 20 mg/kg OXA solution once a week for 6 consecutive weeks. The body weight of the mice was recorded every day. The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined. Hematoxylin and eosin staining, Sirius red staining and scanning electron microscopy were used to identify pathological changes. mRNA microarray was used to analyze changes in the gene expression profiles mainly from the functional aspects of Gene Ontology and the Kyoto Encyclopedia of Genes and Genomes. The oxidation mechanism was verified by measuring oxidative stress-related markers and reactive oxygen species with dihydroethidium probe technology, according to the microarray results. Among all of the OXA groups, 10 mg/kg OXA resulted in an acceptable survival rate of 78%. The mice showed obvious splenomegaly, increases in serum levels of ALT and AST, aggravation of liver pathological injuries and hepatic sinusoidal injuries. The microarray results suggested that mRNA expression changes after OXA treatment were associated with ‘oxidative stress’, ‘coagulation function’, ‘steroid anabolism’ and ‘pro-inflammatory responses’. The results confirmed that OXA aggravated oxidative damage in the livers of the mice. The present study successfully established a mouse model of OXA-induced HSOS and preliminarily analyzed the underlying molecular mechanisms involved, thus laying a foundation for a subsequent in-depth study. D.A. Spandidos 2022-09-28 /pmc/articles/PMC9551404/ /pubmed/36177905 http://dx.doi.org/10.3892/mmr.2022.12862 Text en Copyright: © Zhu et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zhu, Chen
Cheng, Xinwei
Gao, Ping
Gao, Qianyan
Wang, Ximin
Liu, Dong
Ren, Xiuhua
Zhang, Chengliang
Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
title Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
title_full Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
title_fullStr Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
title_full_unstemmed Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
title_short Model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
title_sort model establishment and microarray analysis of mice with oxaliplatin-induced hepatic sinusoidal obstruction syndrome
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551404/
https://www.ncbi.nlm.nih.gov/pubmed/36177905
http://dx.doi.org/10.3892/mmr.2022.12862
work_keys_str_mv AT zhuchen modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome
AT chengxinwei modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome
AT gaoping modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome
AT gaoqianyan modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome
AT wangximin modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome
AT liudong modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome
AT renxiuhua modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome
AT zhangchengliang modelestablishmentandmicroarrayanalysisofmicewithoxaliplatininducedhepaticsinusoidalobstructionsyndrome